v3.26.3
Shareholders’ Equity and Equity Compensation - Schedule of Share-Based Payment Arrangement, Option, Activity (Details)
$ / shares in Units, $ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2026
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Number of Options    
Beginning balance (in shares) 21,885,508  
Granted (in shares) 0  
Exercised (in shares) (5,006,474)  
Forfeited or expired (in shares) (621,836)  
Ending balance (in shares) 16,257,198 21,885,508
Total exercisable (in share) 13,042,687  
Total vested or expected to vest (in shares) 15,894,218  
Weighted Average Exercise Price Per Share    
Beginning balance (in dollars per share) | $ / shares $ 10.23  
Granted (in dollars per share) | $ / shares 0  
Exercised (in dollars per share) | $ / shares 5.75  
Forfeited or expired (in dollars per share) | $ / shares 17.52  
Ending balance (in dollars per share) | $ / shares 11.33 $ 10.23
Total exercisable (in dollars per share) | $ / shares 9.72  
Total vested or expected to vest (in dollars per share) | $ / shares $ 11.17  
Weighted Average Remaining Contract Term    
Total outstanding as of December 31, 2025: 4 years 10 months 9 days 4 years 11 months 26 days
Total outstanding as of September 30, 2026 4 years 10 months 9 days 4 years 11 months 26 days
Total exercisable as of September 30, 2026 4 years 2 months 23 days  
Total vested or expected to vest as of September 30, 2026 4 years 9 months 18 days  
Aggregate Intrinsic Value    
Total outstanding as of December 31, 2025: | $ $ 366,605  
Total outstanding as of September 30, 2026 | $ 328,714 $ 366,605
Total exercisable as of September 30, 2026 | $ 284,721  
Total vested or expected to vest as of September 30, 2026 | $ $ 323,850  
Options exercised but not settled (in shares) 101